| 000 | 01770 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513075546.0 | ||
| 264 | 0 | _c19931029 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00070a004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRao, C M | |
| 245 | 0 | 0 |
_aSpecificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cSep 1993 |
||
| 300 |
_a2614-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCathepsin D _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCathepsin E |
| 650 | 0 | 4 |
_aCathepsins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aDipeptides _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aMorpholines _xchemistry |
| 650 | 0 | 4 |
_aPepsin A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aRenin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aScarborough, P E | |
| 700 | 1 | _aKay, J | |
| 700 | 1 | _aBatley, B | |
| 700 | 1 | _aRapundalo, S | |
| 700 | 1 | _aKlutchko, S | |
| 700 | 1 | _aTaylor, M D | |
| 700 | 1 | _aLunney, E A | |
| 700 | 1 | _aHumblet, C C | |
| 700 | 1 | _aDunn, B M | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 36 _gno. 18 _gp. 2614-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00070a004 _zAvailable from publisher's website |
| 999 |
_c8410246 _d8410246 |
||